{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "70436-014",
      "generic_name": "olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide",
      "labeler_name": "Slate Run Pharmaceuticals, LLC",
      "brand_name": "olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide",
      "active_ingredients": [
        {
          "name": "OLMESARTAN MEDOXOMIL",
          "strength": "20 mg/1"
        },
        {
          "name": "AMLODIPINE BESYLATE",
          "strength": "5 mg/1"
        },
        {
          "name": "HYDROCHLOROTHIAZIDE",
          "strength": "12.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "70436-014-04",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (70436-014-04)",
          "marketing_start_date": "20250515",
          "sample": false
        },
        {
          "package_ndc": "70436-014-06",
          "description": "90 TABLET, FILM COATED in 1 BOTTLE (70436-014-06)",
          "marketing_start_date": "20250515",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Slate Run Pharmaceuticals, LLC"
        ],
        "rxcui": [
          "999967",
          "999986",
          "999991",
          "999996",
          "1000001"
        ],
        "spl_set_id": [
          "a469adff-25a6-4983-b471-60924d920a86"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0370436018048",
          "0370436016044",
          "0370436014040",
          "0370436015047",
          "0370436017041"
        ],
        "nui": [
          "N0000175359",
          "N0000175419",
          "M0471776"
        ],
        "pharm_class_pe": [
          "Increased Diuresis [PE]"
        ],
        "pharm_class_epc": [
          "Thiazide Diuretic [EPC]"
        ],
        "pharm_class_cs": [
          "Thiazides [CS]"
        ],
        "unii": [
          "6M97XTV3HD",
          "864V2Q084H",
          "0J48LPH2TH"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "d306cb9e-4244-49dd-9297-9cb6ca69cae9",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250515",
      "product_id": "70436-014_d306cb9e-4244-49dd-9297-9cb6ca69cae9",
      "application_number": "ANDA210718",
      "brand_name_base": "olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide",
      "pharm_class": [
        "Angiotensin 2 Receptor Antagonists [MoA]",
        "Angiotensin 2 Receptor Blocker [EPC]",
        "Calcium Channel Antagonists [MoA]",
        "Calcium Channel Blocker [EPC]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Dihydropyridine Calcium Channel Blocker [EPC]",
        "Dihydropyridines [CS]",
        "Increased Diuresis [PE]",
        "Thiazide Diuretic [EPC]",
        "Thiazides [CS]"
      ]
    }
  ]
}